Gyrus Capital to acquire LivaNova’s heart valve business
The divestment of the HV business will help LivaNova to focus more on its neuromodulation and cardiovascular segments
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Dec 20
The divestment of the HV business will help LivaNova to focus more on its neuromodulation and cardiovascular segments
03 Dec 20
Muvr platform comprises patient wearables, mobile device applications and chatbot texting for remote monitoring of patient recovery
03 Dec 20
The DPP Respiratory Antigen Panel test system is intended to provide simultaneous, discrete, and differential detection of Influenza…
01 Dec 20
Source Molecular provides lab-based testing solutions for microbial source tracking of pathogens, including SARS-CoV-2 virus
The DHSC has since responded to BMJ claims that the UK government 'buried' negative data on the accuracy…
17 Nov 20
The acquisition enables Medtronic to offer integrated spine solution with AI-driven surgical planning, personalised spinal implants and robotic…
16 Nov 20
BD is a global medical technology company advancing the world of health by improving medical discovery, diagnostics and…
Cohero Health develops advanced digital tools and technologies to enhance respiratory care and optimise medication utilisation
03 Nov 20
The acquisition will allow Olympus to expand distribution of its orthopaedic products through FH ORTHO’s existing channels
Earlier this month, medical device component supplier Qosina claimed increased production of 3D-printed nasal swabs was needed to…